256 related articles for article (PubMed ID: 17942280)
1. Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophrenia.
O'Connor JA; Hemby SE
Schizophr Res; 2007 Dec; 97(1-3):277-88. PubMed ID: 17942280
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome Alterations in Prefrontal Pyramidal Cells Distinguish Schizophrenia From Bipolar and Major Depressive Disorders.
Arion D; Huo Z; Enwright JF; Corradi JP; Tseng G; Lewis DA
Biol Psychiatry; 2017 Oct; 82(8):594-600. PubMed ID: 28476208
[TBL] [Abstract][Full Text] [Related]
3. AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs.
O'Connor JA; Muly EC; Arnold SE; Hemby SE
Schizophr Res; 2007 Feb; 90(1-3):28-40. PubMed ID: 17141476
[TBL] [Abstract][Full Text] [Related]
4. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
Beneyto M; Meador-Woodruff JH
Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
[TBL] [Abstract][Full Text] [Related]
5. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder.
Arion D; Corradi JP; Tang S; Datta D; Boothe F; He A; Cacace AM; Zaczek R; Albright CF; Tseng G; Lewis DA
Mol Psychiatry; 2015 Nov; 20(11):1397-405. PubMed ID: 25560755
[TBL] [Abstract][Full Text] [Related]
6. The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression.
Law AJ; Harrison PJ
J Psychiatr Res; 2003; 37(6):487-99. PubMed ID: 14563380
[TBL] [Abstract][Full Text] [Related]
7. Altered prefrontal cortical MARCKS and PPP1R9A mRNA expression in schizophrenia and bipolar disorder.
Konopaske GT; Subburaju S; Coyle JT; Benes FM
Schizophr Res; 2015 May; 164(1-3):100-8. PubMed ID: 25757715
[TBL] [Abstract][Full Text] [Related]
8. NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder.
Mueller HT; Meador-Woodruff JH
Schizophr Res; 2004 Dec; 71(2-3):361-70. PubMed ID: 15474907
[TBL] [Abstract][Full Text] [Related]
9. Altered excitatory and inhibitory ionotropic receptor subunit expression in the cortical visuospatial working memory network in schizophrenia.
Schoonover KE; Dienel SJ; Holly Bazmi H; Enwright JF; Lewis DA
Neuropsychopharmacology; 2024 Jun; 49(7):1183-1192. PubMed ID: 38548877
[TBL] [Abstract][Full Text] [Related]
10. COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
Shukla AA; Jha M; Birchfield T; Mukherjee S; Gleason K; Abdisalaam S; Asaithamby A; Adams-Huet B; Tamminga CA; Ghose S
Schizophr Res; 2016 May; 173(1-2):94-100. PubMed ID: 27021555
[TBL] [Abstract][Full Text] [Related]
11. Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression.
Kristiansen LV; Meador-Woodruff JH
Schizophr Res; 2005 Oct; 78(1):87-93. PubMed ID: 16023328
[TBL] [Abstract][Full Text] [Related]
12. Developmental Expression Patterns of GABAA Receptor Subunits in Layer 3 and 5 Pyramidal Cells of Monkey Prefrontal Cortex.
Datta D; Arion D; Lewis DA
Cereb Cortex; 2015 Aug; 25(8):2295-305. PubMed ID: 24610118
[TBL] [Abstract][Full Text] [Related]
13. Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.
Kristiansen LV; Bakir B; Haroutunian V; Meador-Woodruff JH
Schizophr Res; 2010 Jun; 119(1-3):198-209. PubMed ID: 20347576
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study.
Karry R; Klein E; Ben Shachar D
Biol Psychiatry; 2004 Apr; 55(7):676-84. PubMed ID: 15038995
[TBL] [Abstract][Full Text] [Related]
15. Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder.
Meador-Woodruff JH; Hogg AJ; Smith RE
Brain Res Bull; 2001 Jul; 55(5):631-40. PubMed ID: 11576760
[TBL] [Abstract][Full Text] [Related]
16. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics.
Dracheva S; McGurk SR; Haroutunian V
J Neurosci Res; 2005 Mar; 79(6):868-78. PubMed ID: 15696539
[TBL] [Abstract][Full Text] [Related]
17. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder.
Konopaske GT; Lange N; Coyle JT; Benes FM
JAMA Psychiatry; 2014 Dec; 71(12):1323-31. PubMed ID: 25271938
[TBL] [Abstract][Full Text] [Related]
18. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.
Woo TU; Walsh JP; Benes FM
Arch Gen Psychiatry; 2004 Jul; 61(7):649-57. PubMed ID: 15237077
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.
Datta D; Arion D; Corradi JP; Lewis DA
Biol Psychiatry; 2015 Dec; 78(11):775-85. PubMed ID: 25981171
[TBL] [Abstract][Full Text] [Related]
20. Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide.
Dean B; Gibbons AS; Boer S; Uezato A; Meador-Woodruff J; Scarr E; McCullumsmith RE
Aust N Z J Psychiatry; 2016 Mar; 50(3):275-83. PubMed ID: 26013316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
